Immunoglobulin G2, Anti-(Human Cd19 (Antigen)) (Synthetic Human Monoclonal Medi-551 Heavy Chain), Disulfide With Synthetic Human Monoclonal Medi-551 .Kappa.-Chain, Dimer
Diffuse Large B-Cell Lymphoma
MedImmune LLCmonoclonal_antibodyPhase 2Dormant
CCC
54/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 73/ 100
Competitive context
253 Active assets in the Diffuse Large B-Cell Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Vincristine Sulfate National Cancer Institute (NCI) | Phase 2/3 | A |
Melphalan Ruijin Hospital | Phase 4 | BBB |
Axicabtagene Ciloleucel Ruijin Hospital | Phase 4 | BBB |
Cyclosporin A Fred Hutchinson Cancer Center | Phase 3 | BBB |
Nivestim Ruijin Hospital | Phase 3 | BBB |
View all 50 →
Same molecule, other indications
Immunoglobulin G2, Anti-(Human Cd19 (Antigen)) (Synthetic Human Monoclonal Medi-551 Heavy Chain), Disulfide With Synthetic Human Monoclonal Medi-551 .Kappa.-Chain, Dimer is also rated in:
chronic lymphocytic leukemia/small lymphocytic lymphomaDormant
B
Indicative · Phase 2
57 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →